TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study Of 140 patients enrolled, 48.6% had stage IVM1b/c/d disease, ...
Trip.com Group opened its flagshipTrip.com Airline Global Conference (AGC) 2026in Amsterdam, convening global leaders from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results